Patents by Inventor Joseph T. Bass

Joseph T. Bass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
    Publication number: 20220137026
    Abstract: The present invention relates to cells with altered cell cycle control. In particular, the present invention provides cells with altered cell cycle control and uses of such cells to identify metabolically active agents.
    Type: Application
    Filed: January 13, 2022
    Publication date: May 5, 2022
    Inventors: Joseph T. Bass, Clara Bien Peek, Akihiko Taguchi, Mark Perelis, Biliana Marcheva
  • Compositions and methods for identifying metabolically active agents
    Patent number: 11255843
    Abstract: The present invention relates to cells with altered cell cycle control. In particular, the present invention provides cells with altered cell cycle control and uses of such cells to identify metabolically active agents.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: February 22, 2022
    Assignee: Northwestern University
    Inventors: Joseph T. Bass, Clara Bien Peek, Akihiko Taguchi, Mark Perelis, Biliana Marcheva
  • COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
    Publication number: 20190391133
    Abstract: The present invention relates to cells with altered cell cycle control. In particular, the present invention provides cells with altered cell cycle control and uses of such cells to identify metabolically active agents.
    Type: Application
    Filed: September 4, 2019
    Publication date: December 26, 2019
    Inventors: Joseph T. Bass, Clara Bien Peek, Akihiko Taguchi, Mark Perelis, Biliana Marcheva
  • COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
    Publication number: 20180128812
    Abstract: The present invention relates to cells with altered cell cycle control. In particular, the present invention provides cells with altered cell cycle control and uses of such cells to identify metabolically active agents.
    Type: Application
    Filed: July 18, 2017
    Publication date: May 10, 2018
    Inventors: Joseph T. Bass, Clara Bien Peek, Akihiko Taguchi, Mark Perelis, Biliana Marcheva
  • GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT
    Publication number: 20120231022
    Abstract: The disclosure provides, among other things, the use of GLP-1 receptor agonist compounds to enhance sleep, increase the duration and/or intensity of non-rapid eye movement (NREM) sleep, treat NREM sleep disorders, and to treat circadian rhythm sleep disorders. The GLP-1 receptor agonist compounds may be exendins, exendin analogs, GLP-1(7-37), GLP-1(7-37) analogs (e.g., GLP-1(7-36)-NH2) and the like. In one embodiment, the GLP-1 receptor agonist compound is exenatide.
    Type: Application
    Filed: May 27, 2010
    Publication date: September 13, 2012
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Joseph T. Bass, Aaron D. Laposky, Fred W. Turek